Medigene is developing the next generation of effective TCR cell therapies aimed at establishing better...
Sponsored Publications
CYPs have a number of disadvantages, including low stability or inactivity. The Austrian Centre of Industrial...
Vetter strikes out on new pathways to further develop the injection process.
CDMO launches the Vetter Open...
BioEcho GmbH develops kits for the isolation and processing of DNA and RNA with a rapidly expanding portfolio....
TRIANNI’s antibody discovery platform, The Trianni Mouse, represents best-in-class technology for efficient...
The European Biotechnology Science & Industry Guide 2018 provides a wealth of information on companies,...
Share
